Academic Staff

Home > People > Academic Staff

Professor Joey Zu-yao YANG (楊祖耀教授)

BMedSc (PKU), MMedSc (PKU), PhD (CUHK) 

Research Assistant Professor

JC School of Public Health and Primary Care
 

Email: zyang@cuhk.edu.hk

Division

Division of Epidemiology 

Biography

Professor Yang obtained his Bachelor degree in Preventive Medicine and Master Degree in Epidemiology and Biostatistics from Peking University and PhD in Public Health from the Chinese University of Hong Kong. He has been appointed as Research Assistant Professor at the Jockey Club School of Public Health and Primary Care since April 2016.

 

Professor Yang is specialized in methods of epidemiology, including clinical epidemiology and systematic review and meta-analysis. His major research interests include evidence-based medicine, over-diagnosis and over-treatment of chronic diseases such as cardiovascular diseases and cancer, and predictive and prognostic factors in cancer. He has authored more than 50 publications, 24 of which appear in journals with IF>5.

 

Since 2013, Professor Yang has been a Young Fellow of the Evidence-Based Medicine Committee of Chinese Medical Doctor Association, which is the most prestigious organization of evidence-based medicine in China. Professor Yang also serves as a peer reviewer for a number of international journals, such as Cochrane Database of Systematic Reviews, Oncotarget, Scientific Reports, Atmospheric Environment and PLoS One.

Research Interest

  • Evidence-based medicine

  • Over-diagnosis and over-treatment of chronic diseases such as cardiovascular diseases and cancer

  • Predictive and prognostic factors in cancer

 

Selected Publications 

  1. Yang Z, Hackshaw A, Feng Q, Fu X, Zhang Y, Mao C, Tang J. Comparison of gefitinib, erlotinib and afatinib in non-small cell lung cancer: A meta-analysis. Int J Cancer 2017;140(12):2805-2819.

  2. Yang ZY, Yu YY, Yuan JQ, Shen WX, Zheng DY, Chen JZ, Mao C, Tang JL. The prognostic value of phosphatase and tensin homolog negativity in breast cancer: a systematic review and meta-analysis of 32 studies with 4393 patients. Crit Rev Oncol Hematol 2016;101:40-9.

  3. Yang ZY, Di MY, Yuan JQ, Shen WX, Zheng DY, Chen JZ, Mao C, Tang JL. The prognostic value of phosphorylated Akt in breast cancer: a systematic review. Sci Rep 2015;5:7758.

  4. Yang ZY, Scott CA, Mao C, Tang JL, Farmer AJ. Resistance exercise versus aerobic exercise for type 2 diabetes: a systematic review and meta-analysis. Sports Med 2014; 44(4):487-99.

  5. Yang ZY, Liu L, Mao C, Wu XY, Huang YF, Hu XF, Tang JL. Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer. Cochrane Database Syst Rev 2014; 11:CD009948.

  6. Yang ZY, Wu XY, Huang YF, Di MY, Zheng DY, Chen JZ, Ding H, Mao C, Tang JL. Promising biomarkers for predicting the outcomes of patients with KRAS wild-type metastatic colorectal cancer treated with anti-epidermal growth factor receptor monoclonal antibodies: a systematic review with meta-analysis. Int J Cancer 2013; 133(8):1914-25.

  7. Yang ZY, Yuan JQ, Di MY, Zheng DY, Chen JZ, Ding H, Wu XY, Huang YF, Mao C, Tang JL. Gemcitabine plus erlotinib for advanced pancreatic cancer: a systematic review with meta-analysis. PLoS One 2013; 8(3):e57528.

  8. Yang ZY, Mao C, Tang JL. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients. N Engl J Med 2012; 366(8):767.

  9. Yang ZY, Shen WX, Hu XF, Zheng DY, Wu XY, Huang YF, Chen JZ, Mao C, Tang JL. EGFR gene copy number as a predictive biomarker for the treatment of metastatic colorectal cancer with anti-EGFR monoclonal antibodies: meta-analysis. J Hematol Oncol 2012;5(1):52.

  10. Yang ZY, Mao C, Tang JL. Depression and Risk of Stroke. JAMA 2011; 306(23):2562-3.

​​More Publications

Please reload